Triplex formation with 2′-O,4′-C-ethylene-bridged nucleic acids (ENA) having C3′-endo conformation at physiological pH

被引:52
作者
Koizumi, M [1 ]
Morita, K
Daigo, M
Tsutsumi, S
Abe, K
Obika, S
Imanishi, T
机构
[1] Sankyo Co Ltd, Exploratory Chem Res Labs, Tokyo 1408710, Japan
[2] Sankyo Co Ltd, Biomed Res Labs, Tokyo 1408710, Japan
[3] Sankyo Co Ltd, Pharmacokinet & Drug Delivery Res Labs, Tokyo 1408710, Japan
[4] Osaka Univ, Grad Sch Pharmaceut Sci, Osaka 5650871, Japan
关键词
D O I
10.1093/nar/gkg416
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Antigenes, which are substances that inhibit gene expression by binding to double-stranded DNA (dsDNA) in a sequence-specific manner, are currently sought for the treatment of various gene-related diseases. As such antigenes, we developed new nuclease-resistant oligopyrimidine nucleotides that are partially modified with 2'-O, 4'-C-ethylene nucleic acids (ENA), which are constrained in the C3'-endo conformation and can form a triplex with dsDNA at physiological pH. It was found that these oligonucleotides formed triplexes similarly to those partially modified with 2'-O, 4'-C-methylene nucleic acids (2', 4'-BNA or LNA), as determined by UV melting analyses, electromobility shift assays, CD spectral analyses and restriction enzyme inhibition assays. In our studies, oligonucleotides fully modified with ENA have delta torsion angle values that are marginally higher than those of 2', 4'-BNA/LNA. ENA oligonucleotides present in 10-fold the amount of dsDNA were found to be favorable in forming triplexes. These results provide useful information for the future design of triplex-forming oligonucleotides fully modified with such nucleic acids constrained in the C3'-endo conformation considering that oligonucleotides fully modified with 2', 4'-BNA/LNA do not form triplexes.
引用
收藏
页码:3267 / 3273
页数:7
相关论文
共 42 条
[1]   Conformational and thermodynamic properties of parallel intramolecular triple helices containing a DNA, RNA, or 2′-OMeDNA third strand [J].
Asensio, JL ;
Carr, R ;
Brown, T ;
Lane, AN .
JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 1999, 121 (48) :11063-11070
[2]   Antisense oligonucleotides as a tool for gene functionalization and target validation [J].
Bennett, CF ;
Cowsert, LM .
BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1999, 1489 (01) :19-30
[3]   SELECTION OF SINGLE-STRANDED-DNA MOLECULES THAT BIND AND INHIBIT HUMAN THROMBIN [J].
BOCK, LC ;
GRIFFIN, LC ;
LATHAM, JA ;
VERMAAS, EH ;
TOOLE, JJ .
NATURE, 1992, 355 (6360) :564-566
[4]  
DELEEUW HPM, 1980, ISRAEL J CHEM, V20, P108
[5]  
DURLAND RH, 1991, PROSPECTS ANTISENSE, P219
[6]   X-ray crystal structure of a locked nucleic acid (LNA) duplex composed of a palindromic 10-mer DNA strand containing one LNA thymine monomer [J].
Egli, M ;
Minasov, G ;
Teplova, M ;
Kumar, R ;
Wengel, J .
CHEMICAL COMMUNICATIONS, 2001, (07) :651-652
[7]   Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo [J].
Faria, M ;
Spiller, DG ;
Dubertret, C ;
Nelson, JS ;
White, MRH ;
Scherman, D ;
Hélène, C ;
Giovannangeli, C .
NATURE BIOTECHNOLOGY, 2001, 19 (01) :40-44
[8]  
Faruqi AF, 1996, MOL CELL BIOL, V16, P6820
[9]   The ups and downs of nucleic acid duplex stability: structure-stability studies on chemically-modified DNA:RNA duplexes [J].
Freier, SM ;
Altmann, KH .
NUCLEIC ACIDS RESEARCH, 1997, 25 (22) :4429-4443
[10]   Fomivirsen - Clinical pharmacology and potential drug interactions [J].
Geary, RS ;
Henry, SP ;
Grillone, LR .
CLINICAL PHARMACOKINETICS, 2002, 41 (04) :255-260